Aethlon Medical has enrolled the first patient in its Australian clinical trial evaluating the safety, feasibility, and ...

A patient safety review is underway after a 48-year-old man went in ... Kennedy, who has been living in Winnipeg but is ...

Palvella Therapeutics announced the first patient has been dosed in SELVA, a multicenter, Phase 3 clinical trial designed to evaluate the ...

ORGO earnings call for the period ending September 30, 2024. Organogenesis ( ORGO -1.43%) Q3 2024 Earnings Call Nov 12, 2024, ...

Patient advocates are hoping for change under new director Michelle Tarver, while industry groups look to build on former ...

AIIMS Delhi initiates GRASSROOT trial to assess a new brain stent for stroke clot treatment, tailored for Indian health needs ...

Research about whether CBD improves fibromyalgia symptoms is sparse. However, read on to learn about existing evidence and ...

The New York Yankees banned two fans, Austin Capobianco and John Peter, from Game 5 of the World Series on Wednesday night ...

Opinion: The tiny tattoos of radiation therapy many cancer patients receive take an emotional toll — but they're increasingly ...

Just 15% of patients have their filters taken out despite clear recommendations they should be removed as soon as feasible.

We expect to enroll the first patient in the study in the first quarter of 2025 ... And I think it also speaks to certepetide's benign safety profile that while we hope it has significant impact on ...

New real-world data from Providence, Illumina (NASDAQ: ILMN), and Microsoft Research reveals that Comprehensive Genomic Profiling (CGP), when done early in a cancer patient’s diagnosis, leads to ...